Human Fertilisation and Embryology Authority and Human Tissue Authority Review

(asked on 13th October 2017) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, whether the Human Fertilisation and Embryology Authority has fully implemented recommendations 10 and 11 on ovarian hyperstimulation syndrome of the 2013 Review of the Human Fertilisation and Embryology Authority and the Human Tissue Authority.


Answered by
Philip Dunne Portrait
Philip Dunne
This question was answered on 20th October 2017

The Human Fertilisation and Embryology Authority (HFEA) has advised it has fully implemented all the recommendations in the 2013 review.

Recommendation 10 was addressed through the HFEA’s 2014-17 strategy, in particular the commitment to ‘improve the quality and safety of care through our regulatory activities’. In relation to ovarian hyper-stimulation syndrome (OHSS), the HFEA is working with professional organisations and NHS Digital to understand OHSS hospital admissions data, ensure that clinics are complying with existing guidance from the Royal College of Obstetricians and Gynaecologists and to explore where new guidance for clinics is needed. Recommendation 11 required the HFEA to clarify how it cooperates with the Medicines Healthcare products Regulatory Agency, which was subsequently done, but this recommendation did not refer to OHSS.

Reticulating Splines